Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-11-27FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Pantoprazole Sodium from Civica, Inc. (AP submission).
-
FDA approval · 2020-11-27FDA Approved: TALICIA — Supplemental Application (RedHill Biopharma Ltd)
FDA approved a supplemental application for TALICIA (omeprazole magnesium, amoxicillin and rifabutin) from RedHill Biopharma Ltd.
-
FDA approval · 2020-11-27FDA Approved: OMEPRAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals' generic omeprazole.
-
FDA approval · 2020-11-27FDA Approved: OMEPRAZOLE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for omeprazole from Zydus Lifesciences Limited, authorizing a generic omeprazole product. The ap…
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy [NA]
A completed clinical trial comparing reverse hybrid therapy versus concomitant therapy for Helicobacter pylori infection, with results poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-11-20FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for EQUATE LANSOPRAZOLE (lansoprazole) from Wal-Mart Stores Inc.
-
FDA approval · 2020-11-16FDA Approved: OMEPRAZOLE — Supplemental Application (OHM LABORATORIES INC.)
FDA approved a supplemental application for Omeprazole from OHM Laboratories Inc., resulting in an updated approval for the generic product.
-
FDA approval · 2020-11-13FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
FDA approved a supplemental application for Berkley and Jensen Omeprazole (omeprazole) under the BJWC label, allowing continued marketing wi…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: LOAD VS Levofloxacine Concomitant [Phase 4]
Clinical trial update for a Phase 4 study evaluating LOAD vs Levofloxacin concomitant therapy for Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait [Phase 4]
Phase 4 clinical trial comparing regimens for eradication of Helicobacter pylori in Kuwait has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis [Phase 4]
Phase 4 randomized trial comparing triple therapy with a proton pump inhibitor versus vonoprazan for Helicobacter pylori infection.
-
FDA approval · 2020-10-02FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s esomeprazole magnesium as a generic product under an ANDA to treat acid-related disorders, inclu…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori [Phase 4]
Phase 4 trial comparing 14-day doxycycline with bismuth subsalicylate to levofloxacin with tinidazole for Helicobacter pylori infection has …
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease [Phase 4]
Phase 4 trial update evaluating intravenous triple therapy for Helicobacter pylori infection and related complications from active peptic ul…
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy [Phase 4]
A Phase 4 clinical trial evaluating lactoferrin added to standard triple therapy or sequential therapy for Helicobacter pylori infection has…
-
FDA approval · 2020-06-25FDA Approved: ACID REDUCER — Original Application (CVS Pharmacy)
The FDA approved CVS Pharmacy's original application for a generic esomeprazole magnesium product (ACID REDUCER), expanding access to proton…
-
FDA approval · 2020-06-23FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Civica, Inc.)
The FDA approved a supplemental application for pantoprazole sodium submitted by Civica, Inc. with this action representing an approved supp…
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication [Phase 4]
Phase 4 trial comparing clarithromycin-based and furazolidone-based bismuth-containing regimens for Helicobacter pylori eradication complete…
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children [Phase 3]
Phase 3 clinical trial investigating nitazoxanide for Helicobacter pylori infection in children. Recruitment is ongoing.
-
FDA approval · 2020-06-02FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' esomeprazole magnesium as a generic product (Original Application), expanding access to a proton pump i…
-
CLINICAL_TRIALS trial_result · 2020-05-21Clinical Trial Update: Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea [Phase 4]
Phase 4 clinical trial comparing bismuth-containing quadruple therapy with a modified quadruple therapy for Helicobacter pylori eradication …
-
FDA approval · 2020-05-18FDA Approved: LANSOPRAZOLE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for a generic lansoprazole product.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection [Phase 4]
Phase 4 trial investigating antimicrobial susceptibility testing–guided therapy versus empirical therapy for rescue treatment of Helicobacte…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection [Phase 4]
Phase 4 clinical trial comparing antimicrobial susceptibility-guided therapy to empirical therapy for rescue treatment of Helicobacter pylor…
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Triple Therapy With Tegoprazan in H. Pylori Positive Patients [Phase 3]
Phase 3 clinical trial update evaluating triple therapy with tegoprazan in Helicobacter Pylori infection has completed.